Mymetics Corp - Company Profile

Powered by

All the data and insights you need on Mymetics Corp in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Mymetics Corp Strategy Report

  • Understand Mymetics Corp position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Mymetics Corp: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Mymetics Corp patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
KR1020230159621A Application Oral dispersible vaccine comprising virosomes A61K39/21; A61K2039/55588; A61K2039/541; C12N2740/16171; A61K9/1277; A61K9/0053; A61K9/006; A61K2039/55583; A61K39/12; A61K2039/542; A61K47/42; A61K2039/55555; C12N2740/16134; A61K2039/55511; A61K2039/575; A61K47/10; A61K47/26; A61K9/0056; A61K9/1272; A61K2039/5258; C12N2760/16123; A61P31/18; A61K9/2018; A61K9/2063 November 21, 2023
TWI819156B Grant Oral dispersible vaccine comprising virosomes A61K47/10; A61K2039/5258; A61K47/42; A61K9/1277; A61K9/1272; A61K9/006; C12N2740/16134; A61P31/18; A61K2039/541; A61K2039/55588; C12N2740/16171; A61K9/0056; A61K39/12; A61K2039/542; A61K2039/575; A61K2039/55511; A61K39/21; A61K2039/55583; C12N2760/16123; A61K9/0053; A61K2039/55555; A61K9/2063; A61K9/2018; A61K47/26 October 21, 2023
CA2960948C Grant Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby A61K2039/555; A61K2039/55516; A61K2039/55572; A61K39/0011; A61K39/12; A61K39/155; A61K39/39; A61P31/00; A61P31/12; A61P31/14; A61P31/16; A61P31/20; A61P31/22; A61P35/00; A61P37/04; C12N2760/18523; C12N2760/18534; C12N7/00; Y02A50/30 April 04, 2023
US11523988B2 Grant Oral dispersible vaccine comprising virosomes A61K2039/55511; A61K2039/542; A61K2039/55555; A61K47/10; A61K47/42; A61K2039/5258; A61K9/0056; A61K9/1277; C12N2740/16134; A61K47/26; A61P31/18; C12N2740/16171; A61K2039/55583; A61K9/1272; A61K9/006; A61K39/12; C12N2760/16123; A61K2039/575; A61K9/0053 December 13, 2022
US11224571B2 Grant Oral dispersible vaccine comprising virosomes A61K39/12; A61K2039/542; A61K2039/55583; A61K2039/55555; A61K9/0053; A61K2039/575; A61K2039/5258; C12N2740/16134; A61K47/42; A61K47/10; A61K9/006; A61K9/1272; C12N2760/16123; A61K9/0056; C12N2740/16171; A61K47/26; A61K9/1277; A61P31/18; A61K2039/55511 January 18, 2022
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Find out more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer